Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

COUCH Medcomms

- PMLiVE

Sustainability and Environmental Impact in Market Access and Health Economics

As the concept of sustainability gains traction in healthcare, it is beginning to influence how value is assessed and communicated across the Pharmaceutical and Medtech industries. In this article, experts...

Petauri Evidence

- PMLiVE

Medscape at the American Diabetes Association’s 85th Scientific Sessions: Your Sweet Spot for Innovation!

The American Diabetes Association’s 85th Scientific Sessions is almost here, and Medscape is ready to make an impact in the world of diabetes care! With two groundbreaking symposia, 11 dynamic...

Medscape Education

- PMLiVE

MHRA approves SFL’s Aumseqa to treat EGFR-mutated lung cancer in adults

Approximately 43,000 people are diagnosed with lung cancer every year in the UK

- PMLiVE

Otsuka shares promising phase 3 results for sibeprenlimab in rare kidney disease IgAN

The trial will continue to evaluate change in kidney function over two years

- PMLiVE

Improving patients’ mental health: the role of healthcare comms

By Amanda Moulson

- PMLiVE

The outlook for healthcare comms in 2025

By Lorraine Walters and Melissa Kerschen

- PMLiVE

The transformative role of AI in the future of healthcare communications

By Meg Morgan

- PMLiVE

Sharing Educational Outcomes at EHA 2025

Medscape Hematology will be at EHA 2025 to showcase the power of education impact through online abstracts, posters, and 4 symposia.

Medscape Education

ki park of genesis research group interview still

Navigating US market access analytics: A conversation with Ki Park

In the rapidly evolving landscape of healthcare and pharmaceutical market access, data analytics has become a critical component for making informed decisions. We sat down with Ki Park, our Vice...

Genesis Research Group

- PMLiVE

Eli Lilly and Camurus enter cardiometabolic health partnership worth up to $870m

The deal gives Lilly exclusive global rights to incretin products based on Camurus’ technology

- PMLiVE

AstraZeneca’s Calquence approved by EC for first-line chronic lymphocytic leukaemia use

An estimated 27,000 cases of the disease were diagnosed in the UK, France, Germany, Spain and Italy in 2024

- PMLiVE

Conferences: the value of real experience versus virtual convenience

By Hannah Tivey

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links